1-14 of 14
Ahmad S Alotaibi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Reem Alasbali, Riad O. El Fakih, Naeem A. Chaudhri, Saud Alhayli, Fahad Alsharif, Amr Hanbali, Feras Abdulaziz Alfraih, Marwan Shaheen, Mansour Alfayez, Alfadel Alshaibani, Abdulwahab Albabtain, Ahmad S. Alotaibi, Hadeel Samarkandi, Ahmed Kotb Abdrabou, Ayman Saad, Abdullah Alamer, Tusneem Ahmed M Elhassan, Walid Rasheed, Fahad Almohareb, Hazza A. Alzahrani, Syed Osman Ahmed, Mahmoud Aljurf, ALI D Alahmari
Journal: Blood
Blood (2023) 142 (Supplement 1): 6951.
https://doi.org/10.1182/blood-2023-182333
Published: 2023
Journal Articles

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Mostafa Faisal Mohammed Saleh, Ahmed Kotb Abdrabou, Yahya Hummadi, Nader Elatassi, Taimor Hussain, Haroon Alfadhil, Ahmed Bin salman, Momen Nassani, Yazeed Bajuaifer, Mohamed Isam Sharif, Marwa Nassar, Sarah Samarkandi, Heba Madien, Amal Hejab, Ahmed Alnughmush, Ruah Alyamany, Abdullah Alamer, Ayman Saad, Mansour Alfayez, Abdulwahab Albabtain, Ahmad S. Alotaibi, Alfadel Alshaibani, Saud Alhayli, Marwan Shaheen, Ali D Alahmari, Feras Abdulaziz Alfraih, Riad Elfakih, Syed Osman Ahmed, Walid Rasheed, Naeem A. Chaudhri, Fahad Alsharif, Hazza A Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Amr Hanbali
Journal: Blood
Blood (2023) 142 (Supplement 1): 7101.
https://doi.org/10.1182/blood-2023-185676
Published: 2023
Journal Articles

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Manar Aleid, Abdullah Alrajhi, Mohammmad Alwadi, Ali Alsugair, Hassan Alshehri, Imran K Tailor, Amr Hanbali, Feras Abdulaziz Alfraih, Saud Alhayli, Ali Alahmari, Abdulwahab Albabtain, Ahmad S. Alotaibi, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Hazza A Alzahrani, Mohammed A Marei, Ayman Saad, Mahmoud Aljurf, Riad Elfakih, Muhned Alhumaid, Mansour Alfayez
Journal: Blood
Blood (2023) 142 (Supplement 1): 5889.
https://doi.org/10.1182/blood-2023-180221
Published: 2023
Journal Articles

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Manar Alfaham, Ahmad S. Alotaibi, Walid Rasheed, Abdullah Alsuwaidan, Ghulam Mufti, Marwan Shaheen, Mansour Alfayez, Ahmed Alfares, Balqees Alzayed, Nasir Bakshi, Haitham A. Khogeer, Midrar Alhossiny, Najlaa Filimban, Naeem A. Chaudhri, Fahad Almohareb, Amal Hejab, Ruah Alyamany, Ahmed Alnughmush, Fahad Alsharif, Amr Hanbali, Feras Abdulaziz Alfraih, Saud Alhayli, Ali D Alahmari, Alfadel Alshaibani, Abdulwahab Albabtain, Ayman Saad, Abdullah Alamer, Ahmed Abdrabou, Ahmed Bin salman, Alfadil Haroon, Taimoor Hussain, Mostafa Faisal Mohammed Saleh, Sarah Samarkandi, Momen Nassani, Yazeed Bajuaifer, Mohamed Isam Sharif, Heba Madien, Reem Alasbali, Marwa Nassar, Fahad Bahkali, Deemah Almarrzoq, Sahar Ramadan, Riad Youniss, Brian Meyer, Riad Elfakih, Hazza A Alzahrani, Mahmoud Aljurf, Syed Osman Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 7433.
https://doi.org/10.1182/blood-2023-187940
Published: 2023
Journal Articles

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Ali Alsugair, Syed O. Ahmed, Mohamed Isam Sharif, Tusneem Elhassan, Hazza A. Alzahrani, Fahed Almhareb, Naeem A. Chaudhri, Fahad Alsharif, Walid Rasheed, Amr Hanbali, Feras Abdulaziz Alfraih, Marwan Shaheen, Riad El Fakih, Saud Alhayli, Ali Alahmari, Alfadel Alshaibani, Abdulwahab Albabtain, Ahmad S. Alotaibi, Mansour Alfayez, Mahmoud Aljurf
Journal: Blood
Blood (2022) 140 (Supplement 1): 10566–10567.
https://doi.org/10.1182/blood-2022-167509
Published: 2022
Journal Articles

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Afnan Al-Sabbagh, Hazza Alzahrani, Majed J. Dasouki, Taimoor Hussain, Ayodele Alaiya, Ali Alahmari, Emad Ghabashi, Raghad Al Ammari, Abdullah Faruk Demirkaya, Moheeb Alawwami, Naeem A. Chaudhri, Fahad Alsharif, Walid Rasheed, Amr Hanbali, Marwan Shaheen, Feras Abdulaziz Alfraih, Riad Elfakih, Shahrukh K. Hashmi, Saud Alhayli, Ahmad S. Alotaibi, Alfadel Alshaibani, Abdulwahab Albabtain, Shaykhah Alotaibi, Mostafa Saleh, Ahmed Abdrabou, Ahmed Bin salman, Haroon Alfadhil, Ahmed Al Sagheir, Riad Youniss, Manju Abraham, Bandar Alotaibi, Sahar Ramadan, Ahmad Alhuraiji, Almohareb Fahad, Mahmoud Aljurf, Syed O. Ahmed
Journal: Blood
Blood (2022) 140 (Supplement 1): 11471–11473.
https://doi.org/10.1182/blood-2022-162734
Published: 2022
Journal Articles

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Ahmed Bin Salman, Syed O. Ahmed, Saleha abdul Rab, Hiba Raheel, Areez Shafqat, Saud Alhayli, Alfadel Alshaibani, Naeem A. Chaudhri, Abdulwahab Albabtain, Feras Abdulaziz Alfraih, Mansour Alfayez, Fahad Alsharif, Marwan Shaheen, Amr Suleiman Hanbali, Ahmad S. Alotaibi, Walid Rasheed, Fahed Almhareb, Ali Alahmari, Hazza Alzahrani, Mahmoud Aljurf, Riad El Fakih
Journal: Blood
Blood (2022) 140 (Supplement 1): 12969–12970.
https://doi.org/10.1182/blood-2022-164820
Published: 2022
Journal Articles

An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis

CME Clinical Trials & Observations
Adi Zoref-Lorenz, Jun Murakami, Liron Hofstetter, Swaminathan Iyer, Ahmad S. Alotaibi, Shehab Fareed Mohamed, Peter G. Miller, Elad Guber, Shiri Weinstein, Joanne Yacobovich, Sarah Nikiforow, Benjamin L. Ebert, Adam Lane, Oren Pasvolsky, Pia Raanani, Arnon Nagler, Nancy Berliner, Naval Daver, Martin Ellis, Michael B. Jordan
Journal: Blood
Blood (2022) 139 (7): 1098–1110.
https://doi.org/10.1182/blood.2021012764
Published: 2022
Includes: Supplemental data
Journal Articles

Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia

Ahmad S. Alotaibi, Shad Ahmed, Walid Rasheed, Marwan Shaheen, Nadiah Alobaidi, Ahmad Alnughmush, Amal Hejab, Taimoor Hussain, Ahmed Abdrabou, Haroon Alfadhil, Mostafa Saleh, Ahmed Bin Salman, Majed Altareb, Momen Nassani, Yazeed S Bajuaifer, Mohamed Isam Sharif, Emad Ghabashi, Shaykhah Alotaibi, Riad Youniss, Alfadel Alshaibani, Ali Alahmari, Saud Alhayli, Riad Elfakih, Feras Al Fraih, Amr Suleiman Hanbali, Fahad Alsharif, Naeem A. Chaudhri, Hazza Alzahrani, Fahed Almhareb, Mahmoud Aljurf, Syed O. Ahmed
Journal: Blood
Blood (2021) 138 (Supplement 1): 1851.
https://doi.org/10.1182/blood-2021-152602
Published: 2021
Journal Articles

Risk Factors Associated with 30-Day Unplanned Readmissions for Adult Acute Lymphoblastic Leukemia (ALL)

Veronica A Guerra, MD, Yasmin Alwash, MD, Yan Yuanqing, PhD, Jorge M. Ramos Perez, MD, Guillaume Richard-Carpentier, MD, Ahmad S. Alotaibi, MD, Hycienth O Ahaneku, MD MPH, PhD, Bachar Samra, MD, Arrvind Raghunath, MD, Nitin Jain, MD, Nicholas J. Short, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MD, Alessandra Ferrajoli, MD, Koji Sasaki, MD, Steven M. Kornblau, MD, Zeev E. Estrov, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Elias Jabbour, MD, Tapan M. Kadia, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-142055
Published: 2020
Journal Articles

Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia: Clinical and Immune Biomarkers of Response

Naval Daver, MD, Sreyashi Basu, PhD, Guillermo Garcia-Manero, MD, Hussein A Abbas, MDPhD, Marina Konopleva, MD PhD, Tapan M. Kadia, MD, Courtney D. DiNardo, MD MSCE, Gautam Borthakur, MD, Ahmad S. Alotaibi, MD, Naveen Pemmaraju, MD, Elias Jabbour, MD, Sherry A. Pierce, BSN, BA, Mark Brandt, BS, Koichi Takahashi, MD PhD, Jing Ning, Steven M. Kornblau, MD, Koji Sasaki, MD, Musa Yilmaz, MD, Ghayas C. Issa, MD, Nicholas J. Short, MD, Jairo A. Matthews, Wilmer Flores, Michael Andreeff, MD PhD, Jorge E. Cortes, MD, Farhad Ravandi, MBBS, James P Allison, PhD, Hagop M. Kantarjian, MD, Padmanee Sharma
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–45.
https://doi.org/10.1182/blood-2020-142824
Published: 2020
Journal Articles

A Novel Inflammatory Index Is Sufficient to Identify Hemophagocytic Lymphohistiocytosis in Adult Patients with Hematologic Malignancies

Adi Zoref-Lorenz, MD, Jun Murakami, MD PhD, Liron Hofstetter, MD, Swaminathan P Iyer, MD, Ahmad S. Alotaibi, MD, Peter Miller, MDPhD, Elad Guber, MD, Shiri Weinstein, MD, Joanne Yacobovich, MD MPH, Sarah Nikiforow, MD PhD, Benjamin L. Ebert, MDPhD, Oren Pasvolsky, MD, Pia Raanani, MD, Arnon Nagler, MD, Nancy Berliner, MD, Naval Daver, MD, Martin H Ellis, Michael B. Jordan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-143011
Published: 2020
Journal Articles

Risk Factors Associated with 30-Day Unplanned Readmissions for Adult Acute Myeloid Leukemia (AML)

Veronica A Guerra, MD, Yasmin Alwash, MD, Yan Yuanqing, PhD, Jorge M. Ramos Perez, MD, Guillaume Richard-Carpentier, MD, Ahmad S Alotaibi, Hycienth O Ahaneku, MD MPH, PhD, Bachar Samra, MD, Arrvind Raghunath, MD, Guillermo Montalban-Bravo, MD, Naveen Pemmaraju, MD, Courtney D. DiNardo, MD MSCE, Naval Daver, MD, Gautam Borthakur, MD, Jorge E. Cortes, MD, Farhad Ravandi, MBBS, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-141616
Published: 2020
Journal Articles

Outcomes with Sequential FLT3-Inhibitor (FLT3i) Based Therapies in Patients (pts) with FLT3 -Mutated Acute Myeloid Leukemia (AML) Exposed to Prior FLT3i Based Therapies

Musa Yilmaz, MD, Mansour Alfayez, Tapan M. Kadia, MD, Courtney D. DiNardo, MD MSCE, Gautam Borthakur, MD, Sanam Loghavi, MD, Marina Konopleva, MD PhD, Rashmi Kanagal-Shamanna, MD, Keyur Patel, MD PhD, Elias Jabbour, MD, Guillermo Garcia-Manero, MD, Naveen Pemmaraju, MD, Sherry A. Pierce, BSN, BA, Ghayas C. Issa, MD, Nicholas J. Short, MD, Guillermo Montalban Bravo, MD, Koichi Takahashi, MD PhD, Rita Assi, MD, Ahmad S Alotaibi, Michael Andreeff, MD PhD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Naval Daver, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–24.
https://doi.org/10.1182/blood-2020-139476
Published: 2020